Trial intelligence / Profile preview

Paracetamol vs ibuprofen for patent ductus arteriosus in preterm infants

2013-003883-30Phase 2Completed

Sponsor
Angelini Pharma
Start
Nov 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, open-label trial of acetaminophen in patent ductus arteriosus (PDA) (2 arms), sponsored by Angelini Pharma. Started Nov 2013; status: completed.

02

Drugs

acetaminophen
03

Conditions

patent ductus arteriosus (PDA)

Beyond the preview

Go deeper on 2013-003883-30.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2013-003883-30.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call